InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Willoughby Scott B., SVP, Conseiller Général et Secrétaire. Officer active across 1 companies, notably Sangamo Therapeutics, INC. Cumulatively, 7 disclosures have been logged. The latest transaction was disclosed on 29 April 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€553140 shares@ €3.95080.0004% mcap2.0% of flow
Common Stock
SEC:0001209191-22-026801:0·
€17,2853,976 shares@ €4.34740.012% mcap61.6% of flow
Common Stock
SEC:0001209191-22-025671:0·
€8,2561,566 shares@ €5.27220.0056% mcap29.4% of flow
Common Stock
SEC:0001209191-22-014179:0·
€973140 shares@ €6.94990.0007% mcap100.0% of flow
Common Stock
SEC:0001209191-21-062653·
€973140 shares@ €6.94990.0007% mcap3.5% of flow
Common Stock
SEC:0001209191-21-062653:0·
07,500 shares0
Common Stock
SEC:0001209191-21-051997·
07,500 shares0
Common Stock
SEC:0001209191-21-051997:0·
7 of 7 declarations
About Willoughby Scott B.
Scott B. Willoughby is the Senior Vice President, General Counsel and Secretary of SANGAMO THERAPEUTICS, INC. In this role, he oversees the company's legal affairs and regulatory compliance. Scott brings valuable expertise in the legal field, contributing to SANGAMO's overall strategy.
